Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome

Experimental Neurology

Volumn 247, Issue , 2013, Pages 303-307

  Dalakas, Marinos C ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN G;

ANTIBODY TITER; AUTOIMMUNITY; BRAIN NERVE CELL; CEREBROSPINAL FLUID; ELECTROPHYSIOLOGY; GABAERGIC TRANSMISSION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; NONHUMAN; NOTE; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; STIFF MAN SYNDROME; SYMPTOMATOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; AUTOANTIBODIES; DYSKINESIA, DRUG-INDUCED; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOGLOBULIN G; MALE; STIFF-PERSON SYNDROME;

EID: 84881371442     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.02.010     Document Type: Note

References (39)

1. Alexopoulos H., Dalakas M.C. A critical update on the immunopathogenesis of stiff person syndrome. Eur. J. Clin. Invest. 2010, 40(11):1018-1025.
2. Alexopoulos, H., Akrivou, S., Dalakas, M.C., in press. Search for anti-Glycine receptor antibodies in Stiff-Person Syndrome (SPS). Neurology.
3. Ameli R., Snow J., Rakocevic G., Dalakas M.C. A neuropsychological assessment of phobias in patients with stiff person syndrome. Neurology 2005, 64:1961-1963.
4. Burbelo P.D., Groot S., Dalakas M.C., Iadarola M.J. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem. Biophys. Res. Commun. 2008, 366:1-7.
5. Burns T.M., Jones H.R., Phillips L.H., Bugawan T.L., Erlich H.A., Lennon V.A. Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter. Neurology 2003, 61:1291-1293.
6. Butler M.H., Hayashi A., Ohkoshi N., Villmann C., Becker C.M., Feng G., De Camilli P., Solimena M. Autoimmunity to gephyrin in stiff-man syndrome. Neuron 2000, 26:307-312.
7. Chung S.K., Vanbellinghen J.F., Mullins J.G., Robinson A., Hantke J., Hammond C.L., Gilbert D.F., Freilinger M., Ryan M., Kruer M.C., Masri A., Gurses C., Ferrie C., Harvey K., Shiang R., Christodoulou J., Andermann F., Andermann E., Thomas R.H., Harvey R.J., Lynch J.W., Rees M.I. Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia. J. Neurosci. 2010, 30(28):9612-9620.
8. Dalakas M.C. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr. Treat. Options. Neurol. 2009, 11:102-110.
9. Dalakas M.C., Fujii M., Li M., McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000, 55:1531-1535.
10. Dalakas M.C., Li M., Fujii M., Jacobowitz D.M. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001, 57:780-784.
11. De Camilli P., Thomas A., Cofiell R., Folli F., Lichte B., Piccolo G., Meinck H.M., Austoni M., Fassetta G., Bottazzo G., Bates D., Cartlidge N., Solimena M., Kilimann M.W., et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J. Exp. Med. 1993, 178(6):2219-2223.
12. Dinkel K., Meinck H.M., Jury K.M., Karges W., Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 1998, 44:194-201.
13. Folli F., Solimena M., Cofiell R., Austoni M., Tallini G., Fassetta G., Bates D., Cartlidge N., Bottazzo G.F., Piccolo G., De Camilli P., et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N. Engl. J. Med. 1993, 328:546-551.
14. Geis C., Beck M., Jablonka S., Weishaupt A., Toyka K.V., Sendtner M., Sommer C. Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons. Neurobiol. Dis. 2009, 36:191-199.
15. Geis C., Weishaupt A., Hallermann S., Grünewald B., Wessig C., Wultsch T., Reif A., Byts N., Beck M., Jablonka S., Boettger M.K., Üçeyler N., Fouquet W., Gerlach M., Meinck H.M., Sirén A.L., Sigrist S.J., Toyka K.V., Heckmann M., Sommer C. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 2010, 133(11):3166-3180.
16. Geis C., Weishaupt A., Grünewald B., Wultsch T., Reif A., Gerlach M., Dirkx R., Solimena M., Perani D., Heckmann M., Toyka K.V., Folli F., Sommer C. Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS One 2011, 6(2):e16775.
17. Hansen N., Hansen Niels, Grünewald Benedikt, Weishaupt Andreas, Colaço Maria Nandini, Toyka Klaus V., Sommer Claudia, Geis Christian Human stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp. Neurol. 2013, 239:202-209.
18. Hutchinson M., Waters P., McHugh J., Gorman G., O'Riordan S., Connolly S., Hager H., Yu P., Becker C.M., Vincent A. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008, 71:1291-1292.
19. Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., Aanstoot H.J., Turck C.W., Erlich H., Lennon V., Baekkeskov S. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 1994, 180:595-606.
20. Koerner C., Wieland B., Richter W., Meinck H.M. Stiff-person syndromes: motor cortex hyperexcitability correlates with anti-GAD autoimmunity. Neurology 2004, 62:1357-1362.
21. Levy L.M., Dalakas M.C., Floeter M.K. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann. Intern. Med. 1999, 131:522-530.
22. Levy L.M., Levy-Reis I., Fujii M., Dalakas M.C. Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch. Neurol. 2005, 62:970-974.
23. Manto M.U., Laute M.A., Aguera M., Rogemond V., Pandolfo M., Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann. Neurol. 2007, 61:544-551.
24. McKeon A., Martinez-Hernandez E., Lancaster E., Matsumoto J.Y., Harvey R.J., McEvoy K.M., Pittock S.J., Lennon V.A., Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013, 70:44-50.
25. Meinck H.M., Ricker K., Conrad B. The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine. J. Neurol. Neurosurg. Psychiatry 1984, 47:280-287.
26. Murinson B.B., Butler M., Marfurt K., Gleason S., De Camilli P., Solimena M. Markedly elevated GAD antibodies in SPS: effects of age and illness duration. Neurology 2004, 63:2146-2148.
27. Nemni R., Caniatti L.M., Gironi M., Bazzigaluppi E., De Grandis D. Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies. Neurology 2004, 62:2101-2102.
28. Raju R., Foote J., Banga J.P., Hall T.R., Padoa C.J., Dalakas M.C., Ortqvist E., Hampe C.S. Analysis of GAD65 autoantibodies in stiff-person syndrome patients. J. Immunol. 2005, 175:7755-7762.
29. Raju R., Rakocevic G., Chen Z., Hoehn G., Semino-Mora C., Shi W., Olsen R., Dalakas M.C. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 2006, 129:3270-3276.
30. Rakocevic G., Raju R., Dalakas M.C. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch. Neurol. 2004, 61:902-904.
31. Rakocevic G., Raju R., Semino-Mora C., Dalakas M.C. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 2006, 67:1068-1070.
32. Reetz A., Solimena M., Matteoli M., Folli F., Takei K., De Camilli P. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J. 1991, 10:1275-1284.
33. Saiz A., Blanco Y., Sabater L., Gonzalez F., Bataller L., Casamitjana R., Ramió-Torrentà L., Graus F. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
34. Sandbrink F., Syed N.A., Fujii M.D., Dalakas M.C., Floeter M.K. Motor cortex excitability in stiff-person syndrome. Brain 2000, 123(Pt. 11):2231-2239.
35. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., De Camilli P., Vicari A.M. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N. Engl. J. Med. 1988, 318:1012-1020.
36. Solimena M., Butler M.H., De Camilli P. GAD, diabetes, and stiff-man syndrome: some progress and more questions. J. Endocrinol. Invest. 1994, 17:509-520.
37. Sommer C., Weishaupt A., Brinkhoff J., Biko L., Wessig C., Gold R., Toyka K.V. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 2005, 365:1406-1411.
38. Vianello M., Bisson G., Dal Maschio M., Vassanelli S., Girardi S., Mucignat C., Fountzoulas K., Giometto B. Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies. Autoimmunity 2008, 41:66-73.
39. Vincent A. Stiff, twitchy or wobbly: are GAD antibodies pathogenic?. Brain 2008, 131:2536-2537.